Hire Malavika B Gireesh, a pharma consultant specializing in Clinical Studies, Drug Development and Sterile Manufacturing. See services offered, experience summary, and connect via apicule.
Based in: Canada
Willing to work in: Global
Consultant Type: Independent Consultant
Expertise summary: Malavika B Gireesh is an experienced Pharma Consultant specializing in formulation development, regulatory compliance, and pharmaceutical quality systems. Her background spans drug product lifecycle management, stability studies, and documentation for regulated markets. At apicule, Malavika contributes to regulatory consulting, technical documentation review, and CDMO project coordination, helping clients achieve compliance and accelerate product development.
Malavika B Gireesh specializes in API Process Development, supporting pharmaceutical companies in designing, optimizing, and improving manufacturing processes for active pharmaceutical ingredients. Her work helps strengthen process efficiency, reproducibility, scalability, and product quality while reducing technical challenges during development and production. She contributes to building robust and practical process strategies that support smoother scale-up, better operational control, and stronger manufacturing readiness across API programs.
Malavika has expertise in Aseptic Manufacturing, helping pharmaceutical companies maintain sterile processing standards, strengthen contamination control, and improve compliance across critical manufacturing environments. She supports operations that require careful control of cleanroom practices, aseptic handling, process discipline, and quality-focused execution for sterile products. Her work helps organizations improve manufacturing reliability, reduce contamination risks, and maintain stronger readiness for quality and regulatory expectations.
Malavika supports IND Enabling Studies by helping pharmaceutical companies build the scientific, technical, and development foundation required to advance products toward clinical evaluation. Her work contributes to the coordination of key early-stage activities that support Investigational New Drug submission readiness, development planning, and regulatory preparation. She helps strengthen early development pathways by supporting structured progress, reducing gaps, and improving confidence as products move closer to clinical-stage advancement.
